Webcast Tuesday

Session 23: European and Global ART Monitoring (presentation of the EIM and ICMART data reports)

D. Adamson (U.S.A.)
ICMART World Report: Preliminary data for 2009  
S.J. Dyer (South Africa)
ICMARTs role in national registries: the South Africa story  


Session 24: Culture media. Growing faster growing better?

T. Adeniyi (United Kingdom)
What makes a medium a good medium  
A. Van Montfoort (The Netherlands)
Time for being proactive  


Session 25: ASRM exchange session - Genetic and metabolic consequences for fertility in men and women

D.J. Lamb (U.S.A.)
Genetic and other controversies in the infertile male  


Session 26: Paramedical invited session – Laboratory: The embryo-endometrial interface – role in implantation/developmental success

H. Van de Velde (Belgium)
The contribution of the embryo  
N. Macklon (United Kingdom)
The contribution of the endometrium  

Press conference 2

D. Stoop (Belgium)
Egg banking for social reasons: women feel positive about it, even though many believe they will never use the eggs they have stored  
L. Stocker (United Kingdom)
Women working shifts are at greater risk of miscarriage, menstrual disruption and subfertility  
E. Groeneveld (The Netherlands)
Women who give birth to multiple babies after IVF are at higher risk of breast cancer than mothers of singletons and those who remain childless  
C. Williams (United Kingdom)
Large UK population study finds no increased cancer risk in children born after assisted conception  


Session 27: Genes and chromosomes in oocytes and embryos

L. Hyslop (United Kingdom)
Blastocyst formation, cell proliferation, and NANOG expression are not comprised by cleavage stage vitrification using a closed system  
K. Wong (The Netherlands)
Factors correlated with aneuploidy in human preimplantation embryos  

Session 29: Ovarian stimulation

D. Bodri (Hungary)
Cumulative live birth rates following minimal ovarian stimulation/natural cycle IVF and single embryo transfer in unselected infertile patients: a 3-year, single-centre, Japanese cohort study  
W. Verpoest (Belgium)
The effect of the type of ovarian stimulation protocol on PGD results: a prospective randomised trial  
N. Weiss (The Netherlands)
Continued treatment with clomiphene citrate in subfertile women with World Health Organization type II anovulation who are not pregnant after six ovulatory cycles  
E. Groeneveld (The Netherlands)
Increased breast cancer risk after multiple implantation in IVF: a cohort study  


Session 30: Fertility preservation for medical and non-medical indications

H. Roness (Israel)
Cyclophosphamide triggers follicle activation causing ovarian reserve 'burn out'; AS101 prevents follicle loss and preserves fertility  
D. Stoop (Belgium)
Oocyte banking for anticipated gamete exhaustion (AGE): a follow-up study  
L. Parmegiani (Italy)
Rapid warming increases survival rate of slow frozen (SF) oocytes; randomised controlled study on sibling human oocytes  
K. Winkler (Austria)
Dynamic perifusion culture initiates in vivo-like early follicular growth in prepubertal murine ovarian tissue  
A. Stein (Israel)
A novel method for cryopreservation of very low count human spermatozoa  


Session 31: PGD/PGS

M. Vega (U.S.A.)
Euploid embryos are far more likely to undergo blastulation than aneuploid embryos when based on single blastomere array Comparative Genomic Hybridization (CGH)  
F. Fiorentino (Italy)
Preimplantation genetic screening on day 3 embryos using array comparative genomic hybridization in patients with advanced maternal age: a prospective double blinded randomized controlled trial  
H. Ghevaria (United Kingdom)
Non-reciprocal errors and germinal mosaicism detected by the application of array-CGH to oocytes and polar bodies unexposed to sperm  
S. Morin (U.S.A.)
Is cohort size of euploid blastocysts following comprehensive chromosomal screening predictive of improved outcomes in single embryo transfer cycles  
P. Mir Pardo (Spain)
Re-analysis of whole day-5 embryos using the same arrayCGH platform used for day-3 diagnosis showed a high confirmation rate  


Session 32: Stem cells and translational research

R. Anderson (United Kingdom)
Evaluation of oogonial stem cells and neo-oogenesis in ovaries of girls and women with Turner Syndrome: a pilot study  
I. Virant - Klun (Slovenia)
Borderline ovarian cancer: induced by small putative ovarian stem cells resembling very small embryonic-like stem cells?  
C. Beyazyurek (Turkey)
Successful hematopoietic stem cell transplantation (hsct) in 39 children from healthy siblings conceived after preimplantation human leukocyte antigen (hla) typing  
O. Oktem (Turkey)
Real-time analysis of the growth of human granulosa cells using an impedance-based signal processing system: a new technology for translational research in human reproduction  


Merck Serono Company Symposium: Breakthrough innovation in ART: Science and technologies beyond drugs to maximize success for the benefit of the patients.

F. Ubaldi (Italy)
Clinical Strategies to Maximize Success in ART  


Session 33: Chlamydia trachomatis and tubal infertility, modern insights and lessons from outside reproductive medicine

J.A. Land (The Netherlands)
How does Chlamydia trachomatis cause tubal infertility?  


Session 34: Why sex is good

S. Repping (The Netherlands)
Evolution of sexual reproduction  
J. Turner (United Kingdom)
Meiosis: A highly risky cell division  


Session 35: Paramedical selected oral session - Nursing

E. Dancet (Belgium)
Gaps in fertility patients’ knowledge about the effect of age and lifestyle on pregnancy and miscarriage rates after spontaneous and after medically assisted conception  
V. De Fr*ne (Belgium)
A study of the health-related quality of life in overweight and obese adult women with the polycystic ovary syndrome during a lifestyle modification program  
D. Barber (United Kingdom)
Women's experiences of antenatal services following In Vitro Fertilisation (IVF): a qualitative study  


Session 37: Historical lecture

E.G. Hughes (Canada)
The history of reproduction through ART – a visual journey from caves to chromosomes  


Session 38: Managing relationship through infertility (Organised by Fertility Europe)

H.S. Olafsdottir (Iceland)
Love, sex and infertility. The art of growing as a couple when dealing with infertility  
E. Bor (The Netherlands)
Surviving Infertility: How I never became a dad, but still going strong with my wife  
T. Child (United Kingdom)
Ending fertility treatment- when, why and how should clinicians advise our patients?  


Session 39: Paramedical invited session - Laboratory

A. Wetzels (The Netherlands)
Is there a future for sperm morphology?  


Session 40: Embryo metabolism

A. Chatzimeletiou (Greece)
Metabolic profile of the human embryo and its association with chromosomal abnormalities  
A. Elaimi (United Kingdom)
The effect of GM-CSF on murine embryo development, aneuploidy, DNA fragmentation and morphokinetic parameters analysed using EmbryoScope™  
S. Kleijkers (The Netherlands)
Ammonium accumulates in IVF culture medium but this does not affect the birth weight of the newborn  
J.G. Thompson (Australia)
BMP-15 supplementation to COCs during bovine IVM alters intra-oocyte metabolism by altering the source of NADPH production  


Session 42: Ethical aspects of ART

H. Darby (United Kingdom)
Medical frontiers: debating mitochondria replacement  
I. Raes (Belgium)
Genetic relatedness as one step ahead: how lesbian couples deal with the presence of a single genetic link  
A. Smajdor (United Kingdom)
Redefining reproduction  
A. Ravelingien (Belgium)
The right to know your genetic parents: from open-identity gamete donation to universal paternity testing  


Session 43: Spermatogenesis - the new knowledge

K.M. Wan (United Kingdom)
Dysfunctional spermatogenesis in sickle cell disease and thalassaemia  
L. Harvey (U.S.A.)
Origin of DNA fragmentation: pre- or post-spermiogenesis  


Session 44: Long term outcome of ART

A. Pinborg (Denmark)
Risk of cancer in children and young adults born after IVF – a Nordic cohort study from the CoNARTaS group  
C. Cesta (Sweden)
Psychological distress and involuntary childlessness in women: a register-based Swedish cohort study  
S. Gameiro (United Kingdom)
Correlates of long-term psychosocial adjustment and mental-health care consumption of 7148 women who did infertility treatment  


Session 45: Clinical female infertility

K. Peeraer (Belgium)
Effect of controlled ovarian stimulation with low dose human menopausal gonadotrophin or clomiphene on reproductive outcome after intrauterine insemination: a prospective, multicenter randomized trial  
S. Puri (India)
The impact of Uterine Artery Embolization (UAE) on subsequent fertility when used as a substitute for invasive operations like myomectomy and in obstetrical emergencies  
C. Herbemont (France)
Clinical predictive criteria for live birth following elective single embryo transfer  
J. Bellver (Spain)
Obesity and impaired uterine receptivity: clinical experience from 9,587 first cycles of ovum donation  

Session 46: Epigenetics in reproductive health

Y. Tang (China)
Aberrant DNA methylation of GRB10 gene in human spontaneous abortions after assisted reproduction techniques and natural conception  
K. Sadek (United Kingdom)
Maternal high fat diet during pregnancy impacts on markers of folliculogenesis in the offspring  
K. Swann (United Kingdom)
The effect of different ovarian stimulation protocols on imprinted gene expression and live birth rates in mice  


Session 47: Reproductive surgery

S. Amer (United Kingdom)
Long-term reproductive performance after surgery for ovarian endometrioma  
V. Asfour (United Kingdom)
Predictors for ovarian histological preservation after ovarian torsion, and the possible impact on future fertility  
Y. Cheong (United Kingdom)
To lyse or not to lyse: results from a randomized controlled trial of adhesiolysis versus diagnostic laparoscopy in women with chronic pelvic pain  


Session 48: Challenges of AMH studies

C. Fitzgerald (United Kingdom)
AMH assays: a review of the literature on assay method comparability  
X. Han (Australia)
Pre-mixing samples with assay buffer is an essential pre-requisite for reproducible Antimullerian Hormone (AMH) measurement using the Beckman Coulter Gen II assay (Gen II)  
M. Caanen (The Netherlands)
Anti-mullerian hormone serum levels decrease in female to male transsexual women using testosterone as cross-sex therapy  


Session 49: Protecting and choosing good sperm

R. Gualtieri (Italy)
Treatment of bovine spermatozoa with antioxidants improves embryo production in vitro  
R. Talevi (Italy)
Treatment with zinc, d-aspartate and coenzyme q10 protects human spermatozoa in vitro  
A. Thijssen (Belgium)
Influence of temperature and preparation techniques on sperm quality  
R. Zeirideen Zaid (United Kingdom)
The potential use of consecutive ejaculates for gaining better quality sperm during fertility treatment  


Session 50: Reproduction and society

I. Scholten (The Netherlands)
Do randomized clinical trials in reproductive medicine compare strategies or treatment cycles - a systematic sample review  


Session 51: Fertility awareness

E. Koert (Canada)
"I wish I had known!" - supporting informed reproductive and childbearing-decisions for women and men  
L.E. Bunting (United Kingdom)
The impact of personalising fertility risk information: double blind randomised control trial measuring attentional allocation and physiological reactions to presenting risk information to young women  
I. Daly (United Kingdom)
“I kinda thought it was something if you wanted to do, you could just do it”: women’s understanding of IVF efficacy - implications for clinical practice